NM_001063.4:c.-2A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001063.4(TF):​c.-2A>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.559 in 1,597,522 control chromosomes in the GnomAD database, including 253,921 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.58 ( 26486 hom., cov: 33)
Exomes 𝑓: 0.56 ( 227435 hom. )

Consequence

TF
NM_001063.4 5_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.243

Publications

26 publications found
Variant links:
Genes affected
TF (HGNC:11740): (transferrin) This gene encodes a glycoprotein with an approximate molecular weight of 76.5 kDa. It is thought to have been created as a result of an ancient gene duplication event that led to generation of homologous C and N-terminal domains each of which binds one ion of ferric iron. The function of this protein is to transport iron from the intestine, reticuloendothelial system, and liver parenchymal cells to all proliferating cells in the body. This protein may also have a physiologic role as granulocyte/pollen-binding protein (GPBP) involved in the removal of certain organic matter and allergens from serum. [provided by RefSeq, Sep 2009]
TF Gene-Disease associations (from GenCC):
  • atransferrinemia
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant 3-133746439-A-G is Benign according to our data. Variant chr3-133746439-A-G is described in ClinVar as Benign. ClinVar VariationId is 343422.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.737 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TFNM_001063.4 linkc.-2A>G 5_prime_UTR_variant Exon 1 of 17 ENST00000402696.9 NP_001054.2 P02787Q06AH7A0PJA6
TFNM_001354704.2 linkc.-210A>G 5_prime_UTR_variant Exon 1 of 16 NP_001341633.2
TFNM_001354703.2 linkc.-89-1973A>G intron_variant Intron 7 of 22 NP_001341632.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TFENST00000402696.9 linkc.-2A>G 5_prime_UTR_variant Exon 1 of 17 1 NM_001063.4 ENSP00000385834.3 P02787

Frequencies

GnomAD3 genomes
AF:
0.584
AC:
88821
AN:
151988
Hom.:
26442
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.651
Gnomad AMI
AF:
0.379
Gnomad AMR
AF:
0.637
Gnomad ASJ
AF:
0.511
Gnomad EAS
AF:
0.758
Gnomad SAS
AF:
0.703
Gnomad FIN
AF:
0.500
Gnomad MID
AF:
0.408
Gnomad NFE
AF:
0.532
Gnomad OTH
AF:
0.551
GnomAD2 exomes
AF:
0.600
AC:
129943
AN:
216564
AF XY:
0.595
show subpopulations
Gnomad AFR exome
AF:
0.647
Gnomad AMR exome
AF:
0.733
Gnomad ASJ exome
AF:
0.519
Gnomad EAS exome
AF:
0.769
Gnomad FIN exome
AF:
0.490
Gnomad NFE exome
AF:
0.520
Gnomad OTH exome
AF:
0.540
GnomAD4 exome
AF:
0.556
AC:
803527
AN:
1445416
Hom.:
227435
Cov.:
53
AF XY:
0.559
AC XY:
401412
AN XY:
718488
show subpopulations
African (AFR)
AF:
0.646
AC:
21438
AN:
33208
American (AMR)
AF:
0.723
AC:
31472
AN:
43552
Ashkenazi Jewish (ASJ)
AF:
0.523
AC:
13572
AN:
25942
East Asian (EAS)
AF:
0.766
AC:
29858
AN:
38988
South Asian (SAS)
AF:
0.688
AC:
57933
AN:
84250
European-Finnish (FIN)
AF:
0.503
AC:
23654
AN:
47066
Middle Eastern (MID)
AF:
0.425
AC:
2320
AN:
5456
European-Non Finnish (NFE)
AF:
0.533
AC:
589888
AN:
1107122
Other (OTH)
AF:
0.558
AC:
33392
AN:
59832
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
19547
39094
58640
78187
97734
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17064
34128
51192
68256
85320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.585
AC:
88921
AN:
152106
Hom.:
26486
Cov.:
33
AF XY:
0.586
AC XY:
43560
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.651
AC:
27023
AN:
41510
American (AMR)
AF:
0.637
AC:
9752
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.511
AC:
1774
AN:
3472
East Asian (EAS)
AF:
0.757
AC:
3888
AN:
5136
South Asian (SAS)
AF:
0.702
AC:
3390
AN:
4826
European-Finnish (FIN)
AF:
0.500
AC:
5286
AN:
10580
Middle Eastern (MID)
AF:
0.401
AC:
118
AN:
294
European-Non Finnish (NFE)
AF:
0.532
AC:
36166
AN:
67960
Other (OTH)
AF:
0.557
AC:
1178
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1934
3868
5801
7735
9669
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
760
1520
2280
3040
3800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.543
Hom.:
29886
Bravo
AF:
0.598
Asia WGS
AF:
0.756
AC:
2627
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Atransferrinemia Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.69
CADD
Benign
15
DANN
Benign
0.80
PhyloP100
0.24
PromoterAI
-0.26
Neutral
Mutation Taster
=299/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1130459; hg19: chr3-133465283; COSMIC: COSV53922246; COSMIC: COSV53922246; API